JP2023544267A - 治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成 - Google Patents

治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成 Download PDF

Info

Publication number
JP2023544267A
JP2023544267A JP2023518094A JP2023518094A JP2023544267A JP 2023544267 A JP2023544267 A JP 2023544267A JP 2023518094 A JP2023518094 A JP 2023518094A JP 2023518094 A JP2023518094 A JP 2023518094A JP 2023544267 A JP2023544267 A JP 2023544267A
Authority
JP
Japan
Prior art keywords
gene
endogenous
dhodh
cell line
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023518094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544267A5 (https=
Inventor
ブルーノ・ルイス・デュマ
モハメド・ナビル・ロウニス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JP2023544267A publication Critical patent/JP2023544267A/ja
Publication of JP2023544267A5 publication Critical patent/JP2023544267A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
    • C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2023518094A 2020-09-21 2021-09-21 治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成 Pending JP2023544267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306068.6 2020-09-21
EP20306068 2020-09-21
PCT/EP2021/075864 WO2022058603A1 (en) 2020-09-21 2021-09-21 Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production

Publications (2)

Publication Number Publication Date
JP2023544267A true JP2023544267A (ja) 2023-10-23
JP2023544267A5 JP2023544267A5 (https=) 2024-10-01

Family

ID=72840426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518094A Pending JP2023544267A (ja) 2020-09-21 2021-09-21 治療用タンパク質産生のための高産生性組換えチャイニーズハムスター卵巣細胞株の生成

Country Status (16)

Country Link
US (1) US20240043878A1 (https=)
EP (2) EP4214308B1 (https=)
JP (1) JP2023544267A (https=)
KR (1) KR20230068401A (https=)
CN (1) CN116457468A (https=)
AU (1) AU2021342718A1 (https=)
BR (1) BR112023005002A2 (https=)
CA (1) CA3195524A1 (https=)
ES (1) ES3010648T3 (https=)
HU (1) HUE070250T2 (https=)
IL (1) IL301442A (https=)
MX (1) MX2023003278A (https=)
PL (1) PL4214308T3 (https=)
TW (1) TWI912369B (https=)
WO (1) WO2022058603A1 (https=)
ZA (1) ZA202303597B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12529071B2 (en) 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507282A (ja) * 2008-10-29 2012-03-29 サンガモ バイオサイエンシーズ， インコーポレイテッド グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物
WO2016062837A1 (en) * 2014-10-23 2016-04-28 Sanofi Novel selection marker for cell transfection and protein production
CN110343668A (zh) * 2019-07-23 2019-10-18 珠海联邦制药股份有限公司 一种敲除gs基因的cho细胞株及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
US12497624B2 (en) * 2018-07-13 2025-12-16 Lonza Ltd Methods for improving production of biological products by reducing the level of endogenous protein
WO2020012446A1 (en) * 2018-07-13 2020-01-16 Enzene Biosciences Limited Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom
US12529071B2 (en) * 2019-03-19 2026-01-20 Sanofi Selection marker-comprising cell line and uses thereof for protein production
WO2020243642A2 (en) * 2019-05-31 2020-12-03 The Trustees Of Columbia University In The City Of New York Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507282A (ja) * 2008-10-29 2012-03-29 サンガモ バイオサイエンシーズ， インコーポレイテッド グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物
WO2016062837A1 (en) * 2014-10-23 2016-04-28 Sanofi Novel selection marker for cell transfection and protein production
CN110343668A (zh) * 2019-07-23 2019-10-18 珠海联邦制药股份有限公司 一种敲除gs基因的cho细胞株及其制备方法与应用

Also Published As

Publication number Publication date
IL301442A (en) 2023-05-01
MX2023003278A (es) 2023-04-12
EP4214308B1 (en) 2024-11-20
US20240043878A1 (en) 2024-02-08
AU2021342718A9 (en) 2025-03-27
CN116457468A (zh) 2023-07-18
KR20230068401A (ko) 2023-05-17
EP4214308A1 (en) 2023-07-26
HUE070250T2 (hu) 2025-05-28
PL4214308T3 (pl) 2025-04-14
TWI912369B (zh) 2026-01-21
ZA202303597B (en) 2024-08-28
BR112023005002A2 (pt) 2023-04-18
ES3010648T3 (en) 2025-04-04
WO2022058603A1 (en) 2022-03-24
AU2021342718A1 (en) 2023-06-08
TW202227622A (zh) 2022-07-16
EP4541812A2 (en) 2025-04-23
CA3195524A1 (en) 2022-03-24
EP4541812A3 (en) 2025-06-11
EP4214308C0 (en) 2024-11-20

Similar Documents

Publication Publication Date Title
Ho et al. Generation of monoclonal antibody-producing mammalian cell lines
US20230151392A1 (en) Safe harbor loci
WO2008121324A2 (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
US20220089775A1 (en) Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof
EP4214308B1 (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
JP7609795B2 (ja) 新規選択マーカーを含む細胞株及びタンパク質製造のためのそれらの使用
CN107109435A (zh) 用于细胞转染和蛋白生产的新型选择性标记物
ES2849728T3 (es) Selectividad eficiente de proteínas recombinantes
RU2849601C1 (ru) Получение рекомбинантной линии клеток китайского хомячка, характеризующейся высоким продуцированием, для продуцирования терапевтических белков
CN114026241A (zh) 稳定的靶向整合
HK40096091A (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
HK40096091B (en) Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production
RU2820830C2 (ru) Линия клеток, содержащая новый маркер отбора, и ее применение для продуцирования белков
WO2021003374A2 (en) Host systems comprising inhibitors of a gene-editing protein for production of viral vectors
Yaşlı et al. Evaluation of Recombinant Antibody Production Efficiency in CHO Cells with Sleeping Beauty Transposon Vector System
JP2015519899A (ja) リボソームポリヌクレオチドおよび関連する発現系
Balasubramanian Study of transposon-mediated cell pool and cell line generation in CHO cells
WO2025153530A1 (en) Albumin-targeted endonucleases, compositions, and methods of use
BR112017003074B1 (pt) Vetor, e, métodos de produção de uma proteína recombinante de interesse e de emprego de tunicamicina como um marcador de seleção

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240920

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260203